Titus B. Ball - 10 Jun 2025 Form 4 Insider Report for BeOne Medicines Ltd. (ONC)

Role: Principal Accounting Officer
Signature: /s/ Qing Nian, as Attorney-in-Fact
Issuer symbol: ONC
Transactions as of: 10 Jun 2025
Net transactions value: -$34,620
Form type: 4
Filing time: 12 Jun 2025, 17:51:28 UTC
Previous filing: 05 Sep 2024
Next filing: 04 Sep 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Ball Titus B.	Principal Accounting Officer	C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, SWITZERLAND	/s/ Qing Nian, as Attorney-in-Fact	12 Jun 2025	0001675628

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ONC	Ordinary Shares	Award	$0	+29,601	+67%	$0.000000	73,983	10 Jun 2025	Direct	F1
transaction	ONC	American Depositary Shares	Sale	$34,620	-134	-100%	$258.36	0	11 Jun 2025	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
F2	Each American Depositary Share represents 13 Ordinary Shares.
F3	The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service.